Emtriva (Emtricitabine, FTC)

See also: Drug Interactions | Medication Side Effects

Brand Name:	Emtriva
Generic Name:	Emtricitabine, FTC
Adult Single Dose:	One 200-mg capsule (once a day)
Food & Liquid Restrictions:	None
Drug Class:	NRTI

The Basics

An Overview of Emtriva (Emtricitabine) (Regularly Updated)
To read PDF, click here
From U.S. National Institutes of Health
Emtriva (Emtricitabine, FTC) (January/February 2008)
To read PDF, click here
In Positively Aware, from Test Positive Aware Network
Emtriva (Emtricitabine, FTC) (September 28, 2007)
Basic information on dosing schedules and side effects.
From U.S. Department of Veterans Affairs
Patient Information About Emtriva (Emtricitabine, FTC) (PDF) (December 2006)
From Gilead Sciences, Inc.
FTC (Emtricitabine, Emtriva) (August 15, 2006)
From AIDS Treatment Data Network
Emtricitabine (Emtriva) (April 21, 2006)
To read PDF, click here
From AIDS InfoNet
Emtriva (Emtricitabine) (November 2005)
To read PDF, click here
From The Center for AIDS
Labeling Changes for Emtriva (September 28, 2005)
Specific modifications since the label was last updated are highlighted.
From U.S. Food and Drug Administration
Three New Drugs Approved by FDA (November/December 2003)
An overview of Fuzeon (enfuvirtide, T-20), Reyataz (atazanavir) and Emtriva (emtricitabine, FTC).
In Survival News, from AIDS Survival Project
Access Information for T-20 (Fuzeon), Atazanavir (Reyataz) and FTC (Emtriva) (October 2003)
How to get information about receiving these new HIV medications through ADAPs and Patient Assistance Programs.
To read PDF, click here
In Project Inform Perspective, from Project Inform
The Bottom Line on T-20 (Fuzeon), Atazanavir (Reyataz) and FTC (Emtriva) (October 2003)
Bare-bones highlights of three of this year's new HIV medications.
To read PDF, click here
In Project Inform Perspective, from Project Inform
Approval of Emtriva for Treating HIV (July 2, 2003)
From U.S. Food and Drug Administration
FTC Has Been Approved: What Now? (July 2003)
An analysis of what we know so far -- and what we have yet to learn.
In TAGline, from Treatment Action Group
Separated at Birth: 3TC and FTC (July 2003)
A quick comparison of molecular structures.
In TAGline, from Treatment Action Group
FTC: Once-Daily Mate for Tenofovir? (April 2003)
A summary of study results from CROI 2003.
In IAPAC Monthly, from International Association of Physicians in AIDS Care
Anti-HIV Drug Updates: Emtricitabine (FTC, Coviracil) (January 2003)
In Project Inform Perspective, from Project Inform
New Anti-HIV Therapies: Emtricitabine (January 2003)
From Project Inform

Research

Clinical Trials Using Emtricitabine (Regularly Updated)
U.S. and international trials currently recruiting.
From U.S. National Institutes of Health
Literature Citations for Emtricitabine (Regularly Updated)
From U.S. National Institutes of Health
Emtricitabine and Lamivudine May Be Similar, but Their Resistance Profiles Differ in Important Ways (February 6, 2006)
In The 13th Conference on Retroviruses and Opportunistic Infections
Emtriva: New Pediatric Formulation and Labeling Changes (September 28, 2005)
From U.S. Food and Drug Administration
Gilead, Royalty Pharma to Pay Emory University $525 Million for Rights to Emtricitabine (July 19, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
No Difference Seen in Resistance Profiles of Emtricitabine and Lamivudine (February 25, 2005)
In The 12th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
Two New Fixed-Dose Combinations Approved (August 2, 2004)
From U.S. Food and Drug Administration
Food and Drug Administration to Expedite Decision on Emtricitabine/Tenofovir Pill (May 18, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Drug Development News: Fixed-Dose Combinations (May/June 2004)
The Food and Drug Administration's fast-track approval process for fixed-dose combinations is about to bear fruit.
In GMHC Treatment Issues, from Gay Men's Health Crisis
Emtricitabine: A New Nucleoside Analogue for Once-Daily Antiretroviral Therapy (January 2004)
In Expert Opinion on Investigational Drugs
No PK Interaction Seen Between FTC and AZT or Tenofovir (September 16, 2003)
In The 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, from The Body PRO
FTC Compares Well to 3TC in Triple-NRTI Regimens (September 15, 2003)
In The 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, from The Body PRO
FTC Similar in Most Ways to 3TC (September 15, 2003)
In The 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, from The Body PRO
A New Once a Day Nucleoside: Emtriva -- A New Option in Once Daily HIV Therapy (August 12, 2003)
In STEP Ezine, from Seattle Treatment Education Project
FTC (Emtriva) Approved (July 25, 2003)
In AIDS Treatment News, from AIDS Treatment News
Better Suppression, Adherence With Once-Daily FTC/ddI/Efavirenz Than Most PI-Based Regimens (July 14, 2003)
In The 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, from The Body PRO
Comparison of Once-Daily FTC Vs. Twice-Daily Abacavir in a Regimen for Drug-Naive Patients (July 14, 2003)
In The 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, from The Body PRO
Forty-Eight Week Data From FTC-d4T Comparison in Treatment-Naive Patients (July 14, 2003)
In The 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, from The Body PRO
FTC Potent Within a HAART Regimen in Treatment-Naive HIV-Infected Patients With High Viral Loads (July 14, 2003)
In The 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, from The Body PRO
Incidence of Symptomatic Hyperlactatemia With FTC (July 14, 2003)
In The 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, from The Body PRO
U.S. Approves Emtriva; Gilead Hopes Viread/Emtriva Combo Will Compete With Combivir (July 3, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Anti-HIV Drug Updates -- Three Drugs on the Near Horizon (January 2003)
Research from Barcelona on T-20, atazanavir and emtricitabine.
To read PDF, click here
In Project Inform Perspective, from Project Inform
Coviracil (FTC) Enters the Home Stretch (December 2002)
In GMHC Treatment Issues, from Gay Men's Health Crisis
Research From the 42nd ICAAC: A Nucleoside (FTC) and a Nucleotide (Tenofovir) Outdo d4T (December 2002)
In IAPAC Monthly, from International Association of Physicians in AIDS Care
Drug Company Gets Good News on FTC, Bad News on DAPD (September 2002)
In GMHC Treatment Issues, from Gay Men's Health Crisis
FTC Superiority Over d4T in Phase III Trial (September/October 2002)
To read PDF, click here
In Positively Aware, from Test Positive Aware Network
Coviracil (FTC) Trial Unblinded Early Due to Drug's Superiority (July/August 2002)
In GMHC Treatment Issues, from Gay Men's Health Crisis
Long-Term Efficacy and Safety of Emtricitabine (FTC) in HIV-Positive Adults Switching from a Lamivudine (3TC)-Containing HAART Regimen (December 18, 2001)
In 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2001), from The Body PRO